Hokama A, Kishimoto K, Nakamoto M, Kobashigawa C, Hirata T, Kinjo N, Kinjo F, Kato S, Fujita J. Endoscopic and histopathological features of gastrointestinal amyloidosis. World J Gastrointest Endosc 2011; 3(8): 157-161 [PMID: 21954412 DOI: 10.4253/wjge.v3.i8.157]
Corresponding Author of This Article
Akira Hokama, MD, PhD, Assistant Professor, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0125, Japan. hokama-a@med.u-ryukyu.ac.jp
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Akira Hokama, Kazuto Kishimoto, Tetsuo Hirata, Jiro Fujita, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0125, Japan
Chiharu Kobashigawa, Manabu Nakamoto, Nagisa Kinjo, Fukunori Kinjo, Department of Endoscopy, University Hospital of the Ryukyus, Okinawa 903-0125, Japan
Seiya Kato, Department of Pathology and Cell Biology, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0125, Japan
ORCID number: $[AuthorORCIDs]
Author contributions: Hokama A wrote the manuscript; Hokama A, Kishimoto K, Nakamoto M, Kobashigawa C, Hirata T and Kinjo N performed endoscopic examinations and treated the patients; Hokama A and Kato S performed the pathological examinations; Kinjo F and Fujita J supervised treatment of the patients and preparation of the manuscript.
Correspondence to: Akira Hokama, MD, PhD, Assistant Professor, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0125, Japan. hokama-a@med.u-ryukyu.ac.jp
Telephone: +81-98-8951144 Fax: +81-98-8951414
Received: March 3, 2011 Revised: July 18, 2011 Accepted: August 6, 2011 Published online: August 16, 2011
Abstract
Amyloidosis is a rare disorder, characterized by the extracellular deposition of an abnormal fibrillar protein, which disrupts tissue structure and function. Amyloidosis can be acquired or hereditary, and systemic or localized to a single organ, such as the gastrointestinal (GI) tract. Clinical manifestations may vary from asymptomatic to fatal forms. Primary amyloidosis (monoclonal immunoglobulin light chains, AL) is the most common form of amyloidosis. AL amyloidosis has been associated with plasma cell dyscrasias, such as, multiple myeloma. Secondary amyloidosis is caused by the deposition of fragments of the circulating acute-phase reactant, serum amyloid A protein (SAA). Common causes of AA amyloidosis are chronic inflammatory disorders. Although GI symptoms are usually nonspecific, histopathological patterns of amyloid deposition are associated with clinical and endoscopic features. Amyloid deposition in the muscularis mucosae, submucosa, and muscularis propria has been dominant in AL amyloidosis, leading to polypoid protrusions and thickening of the valvulae conniventes, whereas granular amyloid deposition mainly in the propria mucosae has been related to AA amyloidosis, resulting in the fine granular appearance, mucosal friability, and erosions. As a result, AL amyloidosis usually presents with constipation, mechanical obstruction, or chronic intestinal pseudo-obstruction while AA amyloidosis presents with diarrhea and malabsorption Amyloidotic GI symptoms are mostly refractory and have a negative impact on quality of life and survival. Diagnosing GI amyloidosis requires high suspicion of evaluating endoscopists. Because of the absence of specific treatments for reducing the abundance of the amyloidogenic precursor protein, we should be aware of certain associations between patterns of amyloid deposition and clinical and endoscopic features.
Citation: Hokama A, Kishimoto K, Nakamoto M, Kobashigawa C, Hirata T, Kinjo N, Kinjo F, Kato S, Fujita J. Endoscopic and histopathological features of gastrointestinal amyloidosis. World J Gastrointest Endosc 2011; 3(8): 157-161
Amyloidosis is a rare disorder, characterized by the extracellular deposition of an abnormal fibrillar protein, which disrupts tissue structure and function. Types of amyloidosis are classified based on the identity of the respective precursor protein[1]. Amyloidosis can be acquired or hereditary, and systemic or localized to a single organ, such as the gastrointestinal (GI) tract. Clinical manifestations may vary from asymptomatic to fatal forms. We review the endoscopic and histopathological characteristics of GI amyloidosis with the presentation of our experiences.
TYPES OF AMYLOIDOSIS
Primary amyloidosis (monoclonal immunoglobulin light chains, AL) is the most common form of amyloidosis. AL amyloidosis has been associated with plasma cell dyscrasias, such as multiple myeloma. Secondary amyloidosis is caused by the deposition of fragments of the circulating acute-phase reactant, serum amyloid A protein (SAA). Common causes of AA amyloidosis are chronic inflammatory disorders and infections, including rheumatoid arthritis, Crohn’s disease, familial Mediterranean fever, leprosy and tuberculosis[1,2]. Due to a predominance of infections before 1990, the AA/AL ratio was 1:3; however, the ratio has been 1:17 to 1:38 due to fewer chronic infections and an increasing recognition of AL amyloidosis[3]. Other types of amyloidosis are dialysis-related amyloidosis with the deposition of β2-microglobulins, and autosomal dominant systemic amyloidosis, such as familial amyloidotic polyneuropathy (FAP) with the deposition of genetically variant transthyretin[1,2]. The incidence of the former has declined with the use of high flux hemodialysis.
THE ASSOCIATION OF CLINICAL FEATURES AND ENDOSCOPIC FINDINGS
Presentations of systemic amyloidosis include weakness, weight loss, neuropathy, cardiopathy, nephropathy and arthropathy, all of which can be refractory[1,2]. Among patients with systemic amyloidosis, the involvement in the GI tract is very common. The small intestine is most commonly affected in the GI tract[4,5]. Diagnosis requires confirmation of the presence of amyloid by histopathology using Congo red staining (Figure 1). Although GI symptoms are usually nonspecific and include macroglossia, dysphagia, abdominal pain, hemorrhage, constipation, diarrhea and malabsorption, patterns of amyloid deposition are associated with clinical and endoscopic features[6,7]. Amyloid deposition in the muscularis mucosae, submucosa and muscularis propria has been dominant in AL amyloidosis, leading to polypoid protrusions and thickening of the valvulae conniventes, whereas granular amyloid deposition mainly in the propria mucosae has been related to AA amyloidosis, resulting in the fine granular appearance, mucosal friability and erosions[6]. As a result, AL amyloidosis usually presents with constipation, mechanical obstruction or chronic intestinal pseudo-obstruction, while AA amyloidosis presents with diarrhea and malabsorption[6]. Typical endoscopic images of duodenal lesions in AL amyloidosis at our institute[8] are shown in Figure 1. Characteristic polypoid protrusions and thickening of the folds are presented. In Figure 2,gastroduodenal lesions in AA amyloidosis caused by rheumatoid arthritis are depicted. More friable duodenal mucosa and reddish colonic mucosa of AA amyloidosis caused by familial Mediterranean fever are disclosed in Figures 3 and 4. Table 1 shows a brief comparison of characteristics of AL and AA amyloidosis. In addition, submucosal hematoma, ulcers and hemorrhagic bullous colitis, which may be caused by amyloid infiltration, are other features in the setting of GI bleeding in AL amyloidosis[9,10]. Our experience with hemorrhagic colonic lesions in AL amyloidosis[11] is shown in Figure 5. Characteristic yellowish plaque-like infiltrative lesions, submucosal hematoma and ulceration are presented.
Table 1 Comparison of characteristics of amyloid light chains and amyloid A amyloidosis[1,2,6,7].
amyloid light chains amyloidosis
amyloid A amyloidosis
Causes
Idiopathy and plasma cell dyscrasias
Chronic inflammatory disorders and infections
Deposition
Monoclonal immunoglobulin light chains
Serum amyloid A protein
Gastrointestinal site of amyloid deposition
The muscularis mucosae, submucosa and muscularis propria
The propria mucosae
Gastrointestinal symptoms
Constipation, mechanical obstruction and chronic intestinal pseudo-obstruction
Figure 1 Endoscopic view of amyloid light chains amyloidosis in a 64-year-old man without multiple myeloma presenting abdominal fullness.
A: Characteristic multiple yellowish-white polypoid protrusions and thickening of the folds in the descending duodenum are presented; B: Biopsy specimens showed marked homogenous eosinophilic deposition in the mucosae and submucosa (HE, × 40); C: Congo red stain confirmed a unique “apple-green” birefringence of the amyloid deposition under polarized light (× 40). All figures and legends are reproduced from[8] with permission from Elsevier.
Figure 2 Endoscopic views of amyloid A amyloidosis in a 45-year-old woman with rheumatoid arthritis.
A: A round ulcer surrounded by longitudinal reddish mucosa is presented in the gastric antrum. Histopathological examination confirmed amyloid deposition; B: Fine granular mucosa in the descending duodenum; C: Biopsy of the duodenal lesion showing marked amorphous eosinophilic deposition in the lamina propria mucosae (HE, × 100); D: Congo red staining showing amyloid deposition (× 100).
Figure 3 Endoscopic views of amyloid A amyloidosis in a 45-year-old man with familial Mediterranean fever.
A: Friable granular mucosa with in the descending duodenum; B: Closer observation revealing whitish dilatated villi with multiple reddish erosions.
Figure 4 Endoscopic views of amyloid A amyloidosis in a 55-year-old man with familial Mediterranean fever.
Patchy reddish mucosa was presented along with submucosal veins. Histopathological examination confirmed amyloid deposition.
Figure 5 Endoscopic views of amyloid light chains amyloidosis in an 80-year-old woman without multiple myeloma presenting hematochezia.
A: Colonoscopy showing a round ulcer in the cecum; B: A patchy yellowish plaque-like infiltrative lesion (arrowheads) relatively normal-appearing intervening mucosae in the transverse colon; C: A tiny submucosal hematoma within pinky plaque-like erythema in the sigmoid colon; D: Biopsy of the colonic lesion showing marked amorphous eosinophilic deposition in the mucosa and submucosa (HE, × 100); E: Congo red staining showing amyloid deposition (× 100). All figures and legends are reproduced from[11] with permission from BMJ Publishing Group Ltd.
As for other types of amyloidosis, dialysis-related β2-microglobulin amyloidosis has a similar present ation to AL amyloidosis[12]. In FAP, endoscopic findings of GI tract are mostly a mild, fine, granular appearance and the amount of amyloid deposition in the mucosa is small compared with that in AL and AA amyloidosis. However, a significant amount of deposition is evident in the nerves of the GI tract, which may be the cause of severe diarrhea and malabsorption occasionally observed in FAP patients despite the mild macroscopic findings[13]. Although recent advances in endoscopy, including narrow-band imaging[14], capsule endoscopy[15,16] and double-balloon enteroscopy[17], have been widely applied to diagnose GI amyloidosis, plain radiographs and radiological barium examination, basic techniques, are still useful in evaluating GI amyloidosis, especially in the small intestine[18,19]. These methods can clearly reveal fold thickening of AL amyloidosis or fine granular mucosa of AA amyloidosis, which corroborate well with the histopathological findings[19,20].
TREATMENT OF AMYLOIDOSIS
Because of the absence of specific treatments for GI amyloidosis, therapy is aimed at reducing the abundance of the amyloidogenic precursor protein, leading to the improvement of amyloidotic organ dysfunction[1]. Treatment of AL amyloidosis includes myeloma-type chemotherapy with melphalan and prednisone and high-dose chemotherapy with hematopoietic stem cell transplantation. Prokinetic agents may benefit dysmotility-related symptoms. Treatment of AA amyloidosis is control of the underlying inflammatory disorders, leading to the reduction of SAA. Diarrhea and malabsorption are often refractory. Supportive measures such as total parenteral nutrition and antidiarrheal agents can be beneficial[1]. GI tract surgery should be performed only if the benefits clearly outweigh the risks.
CONCLUSION
Amyloidotic GI symptoms are mostly refractory and have a negative impact on quality of life and survival. Diagnosing GI amyloidosis requires a high level of suspicion by the evaluating endoscopists; therefore, we should be aware of certain associations between patterns of amyloid deposition and clinical and endoscopic features.
Footnotes
Peer reviewer: Shinji Tanaka, MD, PhD, Professor, Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan; Omar Javed Shah, Professor, Head, Department of Surgical Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir 900100, India
Tada S, Iida M, Iwashita A, Matsui T, Fuchigami T, Yamamoto T, Yao T, Fujishima M. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis.Gastrointest Endosc. 1990;36:10-14.
[PubMed] [DOI][Cited in This Article: ]
Miyaoka M, Matsui T, Hisabe T, Yano Y, Hirai F, Takaki Y, Nagahama T, Beppu T, Murakami Y, Maki S. Clinical and endoscopic features of amyloidosis secondary to Crohn's disease: diagnostic value of duodenal observation and biopsy.Dig Endosc. 2011;23:157-165.
[PubMed] [DOI][Cited in This Article: ]
Tada S, Iida M, Yao T, Kawakubo K, Yao T, Okada M, Fujishima M. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein.Gastrointest Endosc. 1994;40:45-50.
[PubMed] [DOI][Cited in This Article: ]
Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy.Br J Rheumatol. 1996;35:44-49.
[PubMed] [DOI][Cited in This Article: ]
Hokama A, Kinjo F, Kinjo N. Image of the month: primary amyloidosis of the duodenum.Gastroenterology. 2003;125:1302, 1565.
[PubMed] [DOI][Cited in This Article: ]
James DG, Zuckerman GR, Sayuk GS, Wang HL, Prakash C. Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract.Clin Gastroenterol Hepatol. 2007;5:582-588.
[PubMed] [DOI][Cited in This Article: ]
Dray X, Treton X, Joly F, Lavergne-Slove A, Uzunhan Y, Chiche A, Bouhnik Y. Hemorrhagic bullous colitis as a primary manifestation of AL amyloidosis.Endoscopy. 2006;38 Suppl 2:E15-E16.
[PubMed] [DOI][Cited in This Article: ]
Hokama A, Kishimoto K, Azama K, Chinen H, Kinjo F, Kato S, Fujita J. An unusual cause of haematochezia.Gut. 2010;59:728, 793.
[PubMed] [DOI][Cited in This Article: ]
Dulgheru EC, Balos LL, Baer AN. Gastrointestinal complications of beta2-microglobulin amyloidosis: a case report and review of the literature.Arthritis Rheum. 2005;53:142-145.
[PubMed] [DOI][Cited in This Article: ]
Yoshimatsu S, Ando Y, Terazaki H, Sakashita N, Tada S, Yamashita T, Suga M, Uchino M, Ando M. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30).J Intern Med. 1998;243:65-72.
[PubMed] [DOI][Cited in This Article: ]
Hui YT, Lam TW, Yee Lam PW, Yan Wu WH, Lam WM. Narrow-band imaging system with magnifying endoscopy for rectal amyloidosis.Gastrointest Endosc. 2008;68:400-401.
[PubMed] [DOI][Cited in This Article: ]
Pollack MJ, Isenberg GA. Isolated small bowel amyloidosis seen with capsule endoscopy.Gastrointest Endosc. 2007;66:829-30; discussion 830.
[PubMed] [DOI][Cited in This Article: ]
Mandelli G, Radaelli F, Amato A, Terreni N, Paggi S, Spinzi G, Ceretti E, Terruzzi V. The spectrum of small-bowel lesions of AL-type amyloidosis at capsule endoscopy.Endoscopy. 2009;41 Suppl 2:E51-E52.
[PubMed] [DOI][Cited in This Article: ]
Bellutti M, Weigt J, Mönkemüller K, Röcken C, Wieners G, Dombrowski F, Malfertheiner P. Localized primary AL-type amyloidosis of the jejunum diagnosed by double-balloon enteroscopy.Endoscopy. 2007;39 Suppl 1:E134-E135.
[PubMed] [DOI][Cited in This Article: ]
Tada S, Iida M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.Gut. 1993;34:1412-1417.
[PubMed] [DOI][Cited in This Article: ]
Tada S, Iida M, Matsui T, Fuchigami T, Iwashita A, Yao T, Fujishima M. Amyloidosis of the small intestine: findings on double-contrast radiographs.AJR Am J Roentgenol. 1991;156:741-744.
[PubMed] [DOI][Cited in This Article: ]
Tada S, Iida M, Yao T, Kawakubo K, Yao T, Fuchigami T, Okada M, Fujishima M. Gastrointestinal amyloidosis: radiologic features by chemical types.Radiology. 1994;190:37-42.
[PubMed] [DOI][Cited in This Article: ]